Paul Huang, MD
Cardiovascular Disease · Seattle, WANPI 1104882075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Boston Scientific at 35.7% of the total. Reporting peaked in 2020 at $200 and has fallen 76.8% since, to $47 in 2024. That places this record below the midpoint for cardiovascular disease clinicians in WA, where the typical reported total is $606.
Across 12 payments — averaging $39.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$170
- Edwards Lifesciences$111
- Inari Medical, Inc.$62
- Abbott$45
- Philips North America LLC$31
- Terumo Medical Corporation$21
- plus $36 from 3 others
Across 29 payments — averaging $1318.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Recor Medical Inc$34K
- W. L. Gore & Associates, Inc.$2K
- Boston Scientific$2K
- Cvrx, Inc.$295
What the payments were for
- Food & beverage$476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $170 |
| Edwards Lifesciences | 1 | $111 |
| Inari Medical, Inc. | 1 | $62 |
| Abbott | 2 | $45 |
| Philips North America LLC | 1 | $31 |
| Terumo Medical Corporation | 1 | $21 |
| Medtronic | 1 | $17 |
| Ambu Inc. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$476 in reported general payments places this provider in the 40th percentile of 370 cardiovascular disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 128 | $163,231 |
| XareltoRivaroxaban | 105 | $125,480 |
| Repatha SureclickEvolocumab | 31 | $28,137 |
| BrilintaTicagrelor | 17 | $12,066 |
| Rosuvastatin Calcium | 312 | $4,696 |
| Metoprolol Succinate | 280 | $3,616 |
| Ezetimibe | 145 | $3,377 |
| Atorvastatin Calcium | 274 | $3,285 |
| Amlodipine Besylate | 270 | $2,558 |
| ClopidogrelClopidogrel Bisulfate | 200 | $2,503 |
| Losartan Potassium | 208 | $2,465 |
| Carvedilol | 198 | $1,554 |
| Lisinopril | 136 | $1,161 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 100 | $852 |
| Ranolazine ErRanolazine | 23 | $848 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Seattle
- Mariko HarperSeattle$246K
- Gary OppenheimSeattle$153K
- Kelley BranchSeattle$103K
- Erik WissnerSeattle$67K
- Younghoon KwonSeattle$66K
- Aron BenderSeattle$60K
- Vidhushei YogeswaranSeattle$55K
- Santanu BiswasSeattle$30K
- Bhanu GuptaSeattle$27K
- Michael LongoSeattle$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.